Comparison

Ketamine vs ECT

ECT remains the most effective treatment for severe, treatment-resistant depression. Ketamine is faster to access, less invasive, and easier to repeat — but does not match ECT's response rate in the most severe cases.

Written by: Ira ZootMedical review status: Not yet clinically reviewed.Last updated: June 4, 2026Evidence: Educational synthesis - not medical advice

This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.

Quick answer

Bottom line

ECT is the gold standard for severe, life-threatening depression. Ketamine is a powerful and far less invasive option that often comes earlier in the treatment ladder.

This page compares Ketamine and ECT (electroconvulsive therapy) across the same fixed dimensions - mechanism, evidence, onset, duration, side effects, access, suitability, and limits. It does not name a winner and does not recommend either option for you.

Related on Ketalux

Ketamine

ECT (electroconvulsive therapy)

Mechanism

NMDA antagonism, glutamate surge, BDNF-driven synaptic plasticity.

Brief electrical stimulation under general anesthesia triggers a controlled seizure, producing widespread neurochemical and neuroplastic changes.

Evidence

Strong short-term evidence in TRD; growing data on durability with maintenance.

Decades of evidence; highest response and remission rates in severe TRD and psychotic depression.

Onset

Hours to days.

Typically by sessions 4-6 (over 2-3 weeks).

Duration

Days to weeks per session; requires maintenance.

Weeks to months; maintenance ECT often used.

Side effects

Transient dissociation, blood pressure rise, nausea.

Short-term memory loss, headache, muscle soreness, anesthesia risks.

Access

Specialty outpatient clinics.

Hospital-based; requires anesthesia team.

Best for

Moderate-to-severe TRD where rapid relief and outpatient delivery matter.

Severe TRD, psychotic depression, catatonia, acute suicidality, and cases where prior treatments have failed.

Limits

Lower response rates than ECT in the most severe cases.

Stigma, cognitive side effects, access barriers, anesthesia risk.

Disclaimer

This comparison is educational and general. It is not a recommendation. Treatment choice depends on your individual history, diagnosis, prior response, preferences, and access - discuss with a qualified clinician.

About the author

Ira Zoot

Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.